
Freeline Therapeutics has announced that it has entered into a definitive agreement with newly established portfolio company Syncona, in which …

The UK is making a £30 million R&D investment into a promising new type of cancer treatment and is to …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

